Nabriva Therapeutics

NASDAQ: NBRV · Real-Time Price · USD
1.42
0.01 (0.71%)
At close: Jul 31, 2023, 8:00 PM

Nabriva Therapeutics Revenue

Nabriva Therapeutics reported an annual revenue of $35.67M, reflecting a 31.06% growth. For the quarter ending March 31, 2023, Nabriva Therapeutics generated $7.59M in revenue.
Revenue (ttm)
$35.67M
Revenue Growth
31.06%
Price / Sales Ratio
0.14
Revenue / Employee
$914.56K
Employees
39
Market Cap
4.55M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.